Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Statements of Stockholders' Deficit

v3.22.4
Condensed Consolidated Statements of Stockholders' Deficit - USD ($)
$ in Thousands
Total
Warrants
Private Placement
Parent
Parent
Warrants
Parent
Private Placement
Preferred Stock Issued
Common Stock Issued
Common Stock Issued
Warrants
Common Stock Issued
Private Placement
Additional Paid-In Capital
Additional Paid-In Capital
Warrants
Additional Paid-In Capital
Private Placement
Accumulated Deficit
Noncontrolling interest
Beginning balance (in shares) at Aug. 31, 2021             0                
Beginning balance at Aug. 31, 2021 $ 40,920     $ (6,552)     $ 0 $ 0     $ 142,786     $ (149,338) $ 47,472
Beginning balance (in shares) at Aug. 31, 2021               258,631              
Increase (Decrease) in Stockholders' Equity [Roll Forward]                              
Common stock issued for convertible securities (in shares)                 28,500            
Common stock issued for convertible securities   $ 4,183     $ 4,183             $ 4,183      
Stock-based compensation expense 408     408             408        
Remeasurement of IHC temporary equity (13,270)     (13,270)             (13,270)        
Net loss (8,713)     (8,713)                   (8,713)  
Ending balance (in shares) at Nov. 30, 2021             0                
Ending balance (in shares) at Nov. 30, 2021               287,131              
Ending balance at Nov. 30, 2021 $ 30,389     (17,083)     $ 0 $ 0     140,968     (158,051) 47,472
Beginning balance (in shares) at Aug. 31, 2022 8,600,000           8,600,000                
Beginning balance at Aug. 31, 2022 $ (31,494)     (40,988)     $ 1 $ 0     151,736     (192,725) 9,494
Beginning balance (in shares) at Aug. 31, 2022 513,349             513,349              
Increase (Decrease) in Stockholders' Equity [Roll Forward]                              
Fair Market value increase of preferred stock prior to reverse stock split $ 127,145     127,145             127,145        
Preferential dividend of preferred stock (127,145)     (127,145)             (127,145)        
Common stock issued for convertible securities (in shares)             (8,600,000) 8,600,000 124,204            
Common stock issued for convertible securities 0 $ 1   0 $ 1   $ (1) $ 1       $ 1      
Common stock issued, net of offering costs (in shares)                   416,667          
Common stock issued, net of offering costs     $ 4,387     $ 4,387             $ 4,387    
Stock-based compensation expense 255     255             255        
Additional Shares issued due to reverse stock split (in shares)               16,976              
Net loss $ (5,423)     (5,423)                   (5,423)  
Ending balance (in shares) at Nov. 30, 2022 0           0                
Ending balance (in shares) at Nov. 30, 2022 9,671,196             9,671,196              
Ending balance at Nov. 30, 2022 $ (32,168)     $ (41,662)     $ 0 $ 1     $ 156,485     $ (198,148) $ 9,494